The Chennai-based pharmaceutical major, Orchid Chemicals & Pharmaceuticals Ltd has received approvals from the USFDA for three of its ANDAs (Abbreviated New Drug Application) for Cefuroxime for Injection.

The company has received the approval for marketing the drug in the strength of 750 mg & 1.5 g vials (infusion packs), 7.5 g (pharmacy bulk pack) and 1.5 g vial.